SCHEMBL8310876

SCHEMBL8310876

CCC(=O)NCc1cc(Cl)cc(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.55
P2RX7 Q99572 1/20 0.52
ALDH1A1 P00352 2/20 0.47
HPGD P15428 1/20 0.47
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
PDE4D Q08499 1/20 0.42
ERCC1 P07992 1/20 0.41
ERCC4 Q92889 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
CYP11B2 P19099 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31248396 0.82 TACR1 (0.57) TACR1P2RX7ALDH1A1HPGDMEN1
SCHEMBL6361162 0.82 NPC1 (0.59) P2RX7ALDH1A1KMT2ANPC1RAB9A
SCHEMBL30259909 0.82 NPC1 (0.59) P2RX7ALDH1A1KMT2ANPC1RAB9A
SCHEMBL17513342 0.81 TACR1 (0.59) TACR1P2RX7ALDH1A1HPGDMEN1
SCHEMBL7932262 0.81 TACR1 (0.55) TACR1P2RX7ALDH1A1HPGDMEN1
SCHEMBL1709315 0.81 HPGD (0.70) ALDH1A1HPGDMEN1KMT2ANPC1
SCHEMBL23135792 0.80 P2RX7 (0.52) TACR1P2RX7ALDH1A1HPGDMEN1
SCHEMBL4068730 0.80 TACR1 (0.50) TACR1P2RX7ALDH1A1MEN1KMT2A
SCHEMBL19377955 0.80 MEN1 (0.49) TACR1P2RX7ALDH1A1HPGDMEN1
SCHEMBL14672776 0.78 GAA (0.44) ALDH1A1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004089297-A2 COMPOUNDS AND METHODS FOR TREATMENT OF THROMBOSIS SUNTORY PHARMACEUTICAL RESEARCH LABORATORIES, LLC (US) 2004-10-21 WO disclosed